Role of apoptosis in the cytotoxic effect mediated by daunorubicin in cultured human retinal pigment epithelial cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 4, 2002, Pages 377-387

  Wang, Yu Sheng ^a,b   Hui, Yan Nian ^a   Wiedemann, Peter ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; PROTEIN BAX; ANTINEOPLASTIC ANTIBIOTIC; BAX PROTEIN, HUMAN; DNA FRAGMENT; ONCOPROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SIZE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MICROSCOPY; NICK END LABELING; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; VITREORETINOPATHY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; METABOLISM; ULTRASTRUCTURE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELLS, CULTURED; COMPARATIVE STUDY; DAUNORUBICIN; DNA FRAGMENTATION; HUMAN; MICROSCOPY, ELECTRON; PIGMENT EPITHELIUM OF EYE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T; BCL-2-ASSOCIATED X PROTEIN; HUMANS;

EID: 0036668791     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/10807680260218542     Document Type: Article

References (39)

1. The classification of retinal detachment with proliferative vitreoretinopathy
2. Proliferative vitreoretinopathy: An overview
3. Traction retinal detachment. XLIX Edward Jackson Memorial Lecture
4. Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease
5. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy
6. Proliferative vitreoretinopathy and chemotherapeutic agents
7. 1998 Jules Gonin lecture of the Retina Research Foundation. Drug treatment of ocular neovascularization and proliferation
8. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: Results of a multicenter clinical trial
9. Control of experimental massive periretinal proliferation by daunomycin: Dose-response relation
10. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy
11. Cytotoxic effects of daunomycin on retinal pigment epithelium in vitro
12. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells
13. Apoptosis: Cell death in tissue regulation
14. Visible light damage in the primary cultured human retinal pigment epithelial cells
15. A quantitative study of the effect of daunorubicin on AgNORs in cultured human RPE cells
16. Toxicity of daunorubicin on retinal pigment epithelial cells assessed by MTT assay
17. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
18. Cell death and disposal in retinoblastoma: An electron microscopic study
19. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
20. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
21. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
22. Bcl-2 and the regulation of programmed cell death
23. Balancing cell life and death: Bax, apoptosis, and breast cancer
24. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
25. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes
26. An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells
27. The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2
28. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
29. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance
30. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer
31. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
32. Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines
33. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
34. Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction
35. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3
36. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells
37. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells
38. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis
39. CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells